Dried form of Rasnadi Ksheerapaka versus Shatapushpa Curna in Kastartava (Primary Dysmenorrhea)- Clinical Study
Phase 2
- Conditions
- Health Condition 1: N70-N77- Inflammatory diseases of female pelvic organsHealth Condition 2: N944- Primary dysmenorrheaHealth Condition 3: N944- Primary dysmenorrhea
- Registration Number
- CTRI/2024/02/062320
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients within the age group between 14 years to 40 years who are clinically diagnosed with Primary Dysmenorrhea
Patients who are giving consent to the study
Patients with regular menstrual cycle who are suffering from the past three menstrual cycles
Exclusion Criteria
Patients with concomitant genito-urinary infection
Patients who were under hormonal therapy
Dysmenorrhea secondary to any drug intake, Long standing smoking, other systemic disorders
Those who have Perceived Stress Scale 10 greater than 13
Those with Highly sensitive Reactive Protein greater than 3
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement in severity and duration of pain in Primary Dysmenorrhea by Visual Analogue scale and Cox menstrual Scale respectivelyTimepoint: Severity and duration of pain measured at Baseline, Day 3 of first menstrual Cycle, Day 3 of second menstrual cycle, Day 3 of third menstrual cycle, Day 3 of fourth menstrual cycle, Day 3 of fifth menstrual cycle, Day 3 of sixth menstrual cycle
- Secondary Outcome Measures
Name Time Method Improvement in severity of Primary Dysmenorrhea by Verbal Menstrual Questionnarre <br/ ><br>Improvement in Quality of Life by Moos Menstrual Distress Questionnarre <br/ ><br>Improvement in Highly Sensitive Reactive ProteinTimepoint: Severity of Primary Dysmeorrhea will be measured at Baseline, Day 3 of first menstrual cycle, Day 3 of second menstrual cycle, Day 3 of third menstrual cycle, Day 3 of fourth menstrual cycle, Day 3 of fifth menstrual cycle, Day 3 of sixth menstrual cycle. <br/ ><br>Improvement of Quality of Life will be measured at baseline, Day 3 of 6th menstrual cycle. <br/ ><br>Improvement of Highly Sensitive Reactive protein at baseline & Day 3 of first menstrual cycle.